USD 17.83
(-7.33%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 700 Thousand USD | -50.63% |
2021 | 1.41 Million USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | -100.0% |
2023 FY | - USD | -100.0% |
2023 Q4 | 1.74 Million USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q1 | - USD | 100.0% |
2023 Q2 | - USD | 0.0% |
2022 Q3 | - USD | -100.0% |
2022 Q2 | 265 Thousand USD | -40.32% |
2022 FY | 700 Thousand USD | -50.63% |
2022 Q1 | 444 Thousand USD | -47.39% |
2022 Q4 | -9000.00 USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q4 | 844 Thousand USD | 47.04% |
2021 Q1 | - USD | 0.0% |
2021 FY | 1.41 Million USD | 0.0% |
2021 Q3 | 574 Thousand USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Akoya Biosciences, Inc. | 96.63 Million USD | 100.0% |
AngioDynamics, Inc. | 303.91 Million USD | 100.0% |
AtriCure, Inc. | 399.24 Million USD | 100.0% |
Avinger, Inc. | 7.65 Million USD | 100.0% |
Azenta, Inc. | 665.07 Million USD | 100.0% |
BioLife Solutions, Inc. | 143.27 Million USD | 100.0% |
The Cooper Companies, Inc. | 3.59 Billion USD | 100.0% |
Daxor Corporation | 1.28 Million USD | 100.0% |
Ekso Bionics Holdings, Inc. | 18.27 Million USD | 100.0% |
Femasys Inc. | 1.07 Million USD | 100.0% |
GlucoTrack, Inc. | - USD | NaN% |
Harvard Bioscience, Inc. | 112.25 Million USD | 100.0% |
Hologic, Inc. | 4.03 Billion USD | 100.0% |
ICU Medical, Inc. | 2.25 Billion USD | 100.0% |
Intuitive Surgical, Inc. | 7.12 Billion USD | 100.0% |
KORU Medical Systems, Inc. | 28.51 Million USD | 100.0% |
LeMaitre Vascular, Inc. | 193.48 Million USD | 100.0% |
Innovative Eyewear, Inc. | 1.15 Million USD | 100.0% |
Innovative Eyewear, Inc. | 1.15 Million USD | 100.0% |
Masimo Corporation | 2.04 Billion USD | 100.0% |
Microbot Medical Inc. | - USD | NaN% |
Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 100.0% |
Merit Medical Systems, Inc. | 1.25 Billion USD | 100.0% |
Nephros, Inc. | 14.23 Million USD | 100.0% |
NovoCure Limited | 509.33 Million USD | 100.0% |
NEXGEL, Inc. | 4.08 Million USD | 100.0% |
NEXGEL, Inc. | 4.08 Million USD | 100.0% |
Singular Genomics Systems, Inc. | 2.91 Million USD | 100.0% |
OraSure Technologies, Inc. | 405.47 Million USD | 100.0% |
Pro-Dex, Inc. | 53.84 Million USD | 100.0% |
Predictive Oncology Inc. | 1.78 Million USD | 100.0% |
Precision Optics Corporation, Inc. | 19.1 Million USD | 100.0% |
QuidelOrtho Corporation | 2.99 Billion USD | 100.0% |
Repligen Corporation | 638.76 Million USD | 100.0% |
Sanara MedTech Inc. | 64.98 Million USD | 100.0% |
STAAR Surgical Company | 322.41 Million USD | 100.0% |
Sharps Technology, Inc. | - USD | NaN% |
Utah Medical Products, Inc. | 50.22 Million USD | 100.0% |
DENTSPLY SIRONA Inc. | 3.96 Billion USD | 100.0% |
Jin Medical International Ltd. | 19.82 Million USD | 100.0% |